Korean Drug Valuation
| 014570 Stock | KRW 4,610 5.00 0.11% |
At this time, the firm appears to be overvalued. Korean Drug secures a last-minute Real Value of W4002.6 per share. The latest price of the firm is W4610.0. Our model forecasts the value of Korean Drug from analyzing the firm fundamentals such as Return On Equity of 15.3, current valuation of 94.01 B, and Profit Margin of 0.11 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Korean Drug's price fluctuation is very steady at this time. Calculation of the real value of Korean Drug is based on 3 months time horizon. Increasing Korean Drug's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Korean Drug is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Korean Stock. However, Korean Drug's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4610.0 | Real 4002.6 | Hype 4605.0 |
The real value of Korean Stock, also known as its intrinsic value, is the underlying worth of Korean Drug Company, which is reflected in its stock price. It is based on Korean Drug's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Korean Drug's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Korean Drug Co helps investors to forecast how Korean stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Korean Drug more accurately as focusing exclusively on Korean Drug's fundamentals will not take into account other important factors: Korean Drug Total Value Analysis
Korean Drug Co is presently forecasted to have takeover price of 94.01 B with market capitalization of 84.81 B, debt of 15 M, and cash on hands of 4.68 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Korean Drug fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
94.01 B | 84.81 B | 15 M | 4.68 B |
Korean Drug Investor Information
About 50.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Korean Drug had 10:1 split on the 17th of April 2006. Based on the key indicators obtained from Korean Drug's historical financial statements, Korean Drug Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Korean Drug Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Korean Drug has an asset utilization ratio of 84.04 percent. This suggests that the Company is making W0.84 for each dollar of assets. An increasing asset utilization means that Korean Drug Co is more efficient with each dollar of assets it utilizes for everyday operations.Korean Drug Ownership Allocation
The market capitalization of Korean Drug Co is W84.81 Billion. Korean Drug Co holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.Korean Drug Profitability Analysis
The company reported the revenue of 74.47 B. Net Income was 9.04 B with profit before overhead, payroll, taxes, and interest of 28.69 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Korean Drug's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Korean Drug and how it compares across the competition.
About Korean Drug Valuation
The stock valuation mechanism determines Korean Drug's current worth on a weekly basis. Our valuation model uses a comparative analysis of Korean Drug. We calculate exposure to Korean Drug's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Korean Drug's related companies.Korean Drug Co., Ltd. researches, develops, manufactures, and markets medicines for treating human illness in South Korea. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea. KOREAN DRUG is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct Korean Drug's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Korean Drug's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Korean Drug's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Korean Drug's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Korean Drug's revenue streams: Identify Korean Drug's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Korean Drug's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Korean Drug's growth potential: Evaluate Korean Drug's management, business model, and growth potential.
- Determine Korean Drug's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Korean Drug's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Korean Stock analysis
When running Korean Drug's price analysis, check to measure Korean Drug's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Korean Drug is operating at the current time. Most of Korean Drug's value examination focuses on studying past and present price action to predict the probability of Korean Drug's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Korean Drug's price. Additionally, you may evaluate how the addition of Korean Drug to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |